Literature DB >> 21636789

Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development.

Patrick T Reilly1, Samia Afzal, Chiara Gorrini, Koren Lui, Yury V Bukhman, Andrew Wakeham, Jillian Haight, Teo Wei Ling, Carol C Cheung, Andrew J Elia, Patricia V Turner, Tak Wah Mak.   

Abstract

The highly conserved ANP32 proteins are proposed to function in a broad array of physiological activities through molecular mechanisms as diverse as phosphatase inhibition, chromatin regulation, caspase activation, and intracellular transport. On the basis of previous analyses of mice bearing targeted mutations of Anp32a or Anp32e, there has been speculation that all ANP32 proteins play redundant roles and are dispensable for normal development. However, more recent work has suggested that ANP32B may in fact have functions that are not shared by other ANP32 family members. Here we report that ANP32B expression is associated with a poor prognosis in human breast cancer, consistent with the increased levels of Anp32b mRNA present in proliferating wild-type (WT) murine embryonic fibroblasts and stimulated WT B and T lymphocytes. Moreover, we show that, contrary to previous assumptions, Anp32b is very important for murine embryogenesis. In a mixed genetic background, ANP32B-deficient mice displayed a partially penetrant perinatal lethality that became fully penetrant in a pure C57BL/6 background. Surviving ANP32B-deficient mice showed reduced viability due to variable defects in various organ systems. Study of compound mutants lacking ANP32A, ANP32B, and/or ANP32E revealed previously hidden roles for ANP32A in mouse development that became apparent only in the complete absence of ANP32B. Our data demonstrate a hierarchy of importance for the mammalian Anp32 genes, with Anp32b being the most critical for normal development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21636789      PMCID: PMC3121817          DOI: 10.1073/pnas.1106211108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Differential expression of CPD1 during postnatal development in the mouse cerebellum.

Authors:  M Radrizzani; G Vilá-Ortiz; E G Cafferata; M C Di Tella; A González-Guerrico; C Perandones; O H Pivetta; H Carminatti; V P Idoyaga Vargas; T A Santa-Coloma
Journal:  Brain Res       Date:  2001-07-13       Impact factor: 3.252

2.  SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells.

Authors:  Sergey V Anisimov; Kirill V Tarasov; David Tweedie; Michael D Stern; Anna M Wobus; Kenneth R Boheler
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

3.  Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex.

Authors:  Sang-beom Seo; Todd Macfarlan; Peter McNamara; Rui Hong; Yuki Mukai; Soyoung Heo; Debabrata Chakravarti
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

4.  Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock.

Authors:  I E Gallouzi; C M Brennan; J A Steitz
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

5.  Generation and characterization of Smac/DIABLO-deficient mice.

Authors:  Hitoshi Okada; Woong-Kyung Suh; Jianping Jin; Minna Woo; Chunying Du; Andrew Elia; Gordon S Duncan; Andrew Wakeham; Annick Itie; Scott W Lowe; Xiaodong Wang; Tak W Mak
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Generation and characterization of the Anp32e-deficient mouse.

Authors:  Patrick T Reilly; Samia Afzal; Andrew Wakeham; Jillian Haight; Annick You-Ten; Kathrin Zaugg; Joanna Dembowy; Ashley Young; Tak W Mak
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

7.  PAL31, a nuclear protein required for progression to the S phase.

Authors:  W Sun; N Hattori; H Mutai; Y Toyoshima; H Kimura; S Tanaka; K Shiota
Journal:  Biochem Biophys Res Commun       Date:  2001-02-02       Impact factor: 3.575

8.  A gene-expression signature as a predictor of survival in breast cancer.

Authors:  Marc J van de Vijver; Yudong D He; Laura J van't Veer; Hongyue Dai; Augustinus A M Hart; Dorien W Voskuil; George J Schreiber; Johannes L Peterse; Chris Roberts; Matthew J Marton; Mark Parrish; Douwe Atsma; Anke Witteveen; Annuska Glas; Leonie Delahaye; Tony van der Velde; Harry Bartelink; Sjoerd Rodenhuis; Emiel T Rutgers; Stephen H Friend; René Bernards
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

9.  Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway.

Authors:  Xuejun Jiang; Hyun-Eui Kim; Hongjun Shu; Yingming Zhao; Haichao Zhang; James Kofron; Jennifer Donnelly; Dave Burns; Shi-Chung Ng; Saul Rosenberg; Xiaodong Wang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

10.  Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis.

Authors:  Puneet Opal; Jesus J Garcia; Friedrich Propst; Antoni Matilla; Harry T Orr; Huda Y Zoghbi
Journal:  J Biol Chem       Date:  2003-06-14       Impact factor: 5.157

View more
  19 in total

1.  Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.

Authors:  Patrick T Reilly; Yun Yu; Ali Hamiche; Lishun Wang
Journal:  Bioessays       Date:  2014-08-25       Impact factor: 4.345

2.  Overexpression of the pp32r1 (ANP32C) oncogene or its functional mutant pp32r1Y140H confers enhanced resistance to FTY720 (Finguimod).

Authors:  Salma Buddaseth; Wiebke Göttmann; Rainer Blasczyk; Trevor Huyton
Journal:  Cancer Biol Ther       Date:  2013-12-12       Impact factor: 4.742

3.  Gga-miR-181a modulates ANP32A expression and inhibits MDCC-MSB-1 cell.

Authors:  X Li; C Zhao; B Han; L Qu; C Liu; N Yang; L Lian
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-03-08       Impact factor: 2.416

Review 4.  Molecular basis of cleft palates in mice.

Authors:  Noriko Funato; Masataka Nakamura; Hiromi Yanagisawa
Journal:  World J Biol Chem       Date:  2015-08-26

5.  Glycomimetic affinity-enrichment proteomics identifies partners for a clinically-utilized iminosugar.

Authors:  Isa N Cruz; Conor S Barry; Holger B Kramer; C Celeste Chuang; Sarah Lloyd; Aarnoud C van der Spoel; Frances M Platt; Min Yang; Benjamin G Davis
Journal:  Chem Sci       Date:  2013-07-08       Impact factor: 9.825

6.  A comprehensive survey of copy number variation in 18 diverse pig populations and identification of candidate copy number variable genes associated with complex traits.

Authors:  Congying Chen; Ruimin Qiao; Rongxing Wei; Yuanmei Guo; Huashui Ai; Junwu Ma; Jun Ren; Lusheng Huang
Journal:  BMC Genomics       Date:  2012-12-27       Impact factor: 3.969

7.  Direct RNA sequencing mediated identification of mRNA localized in protrusions of human MDA-MB-231 metastatic breast cancer cells.

Authors:  Kristine Raaby Jakobsen; Emilie Sørensen; Karin Kathrine Brøndum; Tina Fuglsang Daugaard; Rune Thomsen; Anders Lade Nielsen
Journal:  J Mol Signal       Date:  2013-09-01

8.  The expression and distributions of ANP32A in the developing brain.

Authors:  Shanshan Wang; Yunliang Wang; Qingshan Lu; Xinshan Liu; Fuyu Wang; Xiaodong Ma; Chunping Cui; Chenghe Shi; Jinfeng Li; Dajin Zhang
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

9.  Targeted ANP32E mutant mice do not demonstrate obvious movement defects.

Authors:  Peiyan Wong; Vonny I Leo; Meijun Low; Tak W Mak; Xiaodong Zhang; Patrick T Reilly
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

10.  ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells.

Authors:  Shuo Yang; Xiao-Na Zhu; Hui-Lin Zhang; Qian Yang; Yu-Sheng Wei; Di Zhu; Meng-Di Liu; Shao-Ming Shen; Li Xia; Ping He; Meng-Kai Ge; Yi-Lian Pan; Meng Zhao; Ying-Li Wu; Jun-Ke Zheng; Guo-Qiang Chen; Yun Yu
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.